Prognostic significance of lymphocyte-to-monocyte ratio in patients with classical Hodgkin lymphoma before and after receiving first-line chemotherapy

por Taha, Heba F., Kamel, Lamiaa Mahmoud, Embaby, Ahmed, Abdelaziz, Lobna A.
Publicado 2022

Tolerability and outcome of sunitinib by giving 4/2 schedule versus 2/1 schedule in metastatic renal cell carcinoma patients: a prospective randomized multi-centric Egyptian study

por Abdelaziz, Lobna A., Taha, Heba F., Ali, Magid M., Abdelgawad, Marwa I., Elwan, Amira
Publicado 2021

Clinical significance of cytokeratin 19 and OCT4 as survival markers in non-metastatic and metastatic breast cancer patients

por Abdelaziz, Lobna A., Ebian, Huda F., Harb, Ola A., Nosery, Yousef, Taha, Heba F., Nawar, Nashwa
Publicado 2022

Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score

por Taha, Heba F., Elsayed, Dalia Hamouda, Salem, Reham, Mandour, Doaa, Bayomy, Mohammed, Rashed, Hayam, Kamel, Mostafa, Elderey, Mohamed, Elfarargy, Ola M.
Publicado 2022

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer

por Elsayed, Dalia Hamouda, Elfarargy, Ola M., Elderey, Mohamed Salah, Mandour, Doaa, Atef, Nora, Hemeda, Rehab, Kamel, Mostafa, Azony, Ahmed, Taha, Heba F.
Publicado 2023